Quality Innovation
Medical Information Systems -
Quality Metrics and Management
Tools in Current and Future
Medical Record Systems
The Quality Innovation webcast series was filmed at the Orthopaedic and Rheumatology Care: Quality Innovation Summit, a live educational activity held May 13-15, 2009.
|
How to Obtain AMA PRA
|
|
Release Date: December 8, 2009
Expiration Date: December 8, 2011
Estimated Time of Completion: 1 hour 15 minutes
Description
The Summit focused on the common and competing interests and visions shaping the assessment of quality in musculoskeletal medicine. The overriding goal was to identify quality assessment practices that effectively measure patient outcomes and that meet the aligned interests of stakeholders which, ultimately, will improve patient care, value, and outcomes.
Discussions included basic principles and methods of quality assessment and management; the varied perspectives of quality from individual stakeholders; current tools for quality assessment; challenges and barriers to advancing quality over the long term; and the evolving clinical, institutional, business, and governmental strategies that will drive the future of quality and performance measures.
This webcast includes the following presentations:
- Regional Health Systems Environment - C. Martin Harris, MD, MBA
- Disease Management - Stephen Rosenberg, MD (Aetna)
- Implementation of EMR-based Musculoskeletal Quality Systems - Eric D. Newman, MD
- Panel Discussion & Questions
Objectives
After completing this activity, the participant will be able to do the following:
- Identify the most pressing problems with rheumatologic care today and list some potential solutions.
- Describe some of the available EMR tools.
- List the primary features of a disease management system supported by medical information systems.
- Describe the concept of most impractical hospitalizations in disease management.
Target Audience
This Summit is an integrated forum for discoveries and networking among clinicians, scientists, health institutions, public and private third-party payers, biomedical industry, and government and nongovernment organizations that share an interest in understanding, promoting, and shaping the future of quality assessment and management practices in musculoskeletal medicine.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
|
George F. Muschler, MD |
Faculty
C. Martin Harris, MD, MBA |
|
Eric D. Newman, MD |
Stephen Rosenberg, MD |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship that, in the context of their presentations, could be perceived as a potential conflict of interest:
| George F. Muschler, MD | ||
| Intellectual Property Rights | DePuy | |
| Stephen Rosenberg, MD | ||
| Employment | Aetna | |
The following faculty have indicated they have no relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:
C. Martin Harris, MD, MBA
Eric D. Newman, MD
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational
grants for partial support of this activity from:
Agency for Healthcare Research and Quality; DePuy Orthopaedics, Inc.; Eli Lilly and Company;
Ethicon Endo-Surgery, Inc.; Merck & Co., Inc.; Pfizer; Smith & Nephew Endoscopy
Funding for this activity was made possible [in part] by grant 1R13 HS018133-01 from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This CME activity was produced by The Cleveland Clinic Center for Continuing Education, and the Cleveland Clinic Orthopaedic and Rheumatologic Institute.









